EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD

被引：0
|
作者：
Fiore, F. [1 ]
Viviani, S. [2 ]
Luminari, S. [3 ]
Levis, A. [4 ]
Di Raimondo, F. [5 ]
Merli, F. [6 ]
Vitolo, U. [7 ]
Bolis, S. [8 ]
Federico, M. [8 ]
Gallamini, A. [1 ]
机构：
[1] Az Osped S Croce & Carle Cuneo, Dept Hematol, Cuneo, CN, Italy
[2] Ist Nazl Tumori Milano, Dept Med Oncol, Milan, Italy
[3] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
[4] Az Osped S Antonio & Biagio, Dept Hematol, Alessandria, Italy
[5] Univ Catania, Hematol Chair, Catania, Italy
[6] Arcispedale S Maria Nuova, Dept Hematol, Reggio Emilia, Italy
[7] Az Osped S Giovanni Battista, Dept Hematol, Turin, Italy
[8] Osped San Gerardo, Dept Hematol, Monza, Italy
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C061
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Early interim FDG-PET during intensified BEACOPP therapy for advancedstage Hodgkin disease shows a lower predictive value than during ABVD
    Gallamini, A.
    Viviaru, S.
    Bonfante, V.
    Levis, A.
    Di Raimondo, F.
    Merli, F.
    Vitolo, U.
    Bolis, S.
    Torchio, P. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 143 - 144
  • [2] Early interim FDG-PET during intensified BEACOPP therapy shows a lower predictive value than during conventional ABVD chemotherapy
    Gallamini, A.
    Viviani, S.
    Bonfante, V.
    Di Raimondo, F.
    Merli, F.
    Vitolo, U.
    Bolis, S.
    Torchio, P.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 71 - 72
  • [3] Early interim FDG-PET overshadows the prognostic role of IPS in advanced-stage Hodgkin lymphoma treated by conventional ABVD therapy
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Vitolo, U.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 32 - 32
  • [4] Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 491 - 498
  • [5] Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 758 - 760
  • [6] Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
    Gallamini, Andrea
    Patti, Caterina
    Viviani, Simonetta
    Rossi, Andrea
    Fiore, Francesca
    Di Raimondo, Francesco
    Cantonetti, Maria
    Stelitano, Caterina
    Feldman, Tatyana
    Gavarotti, Paolo
    Sorasio, Roberto
    Mule, Antonino
    Leone, Monica
    Rambaldi, Alessandro
    Biggi, Alberto
    Barrington, Sally
    Fallanca, Federico
    Ficola, Umberto
    Chauvie, Stephane
    Gianni, Alessandro Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 551 - 560
  • [7] Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
    Gallamini, A.
    Kostakoglu, L.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1045 - 1047
  • [8] Predictive Value of Interim 18FDG-PET on Treatment Outcome in Advanced-Stage Hodgkin's Disease
    Castagnoli, A.
    Rigacci, L.
    Versari, A.
    Gallamini, A.
    Matteini, M.
    Merli, F.
    Nassi, L.
    Peano, S.
    Pelosi, E.
    Gregianin, M.
    Vaggelli, L.
    Levis, A.
    Biggi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S24 - S24
  • [9] RAPID Trial Demonstrates Low Positive Predictive Value of Interim FDG-PET in Early-stage Hodgkin Lymphoma After Three Cycles of ABVD
    Fulbright, Joy M.
    Williams, Sarah E.
    Pahud, Barbara A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 165 - 165
  • [10] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
12345